Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy (VERTIS MET)
All three use tiny doses and have mild side effect profiles
May 12, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity, Practice Management, Type 2 Diabetes, Type 2 Diabetes 1,388 views A patient starts semaglutide through a telehealth platform, receives nutrition advice from a wellness clinic, and later visits a primary care physician for worsening gastrointestinal symptoms
Behavioral and psychological changes at the halfway mark The six-month mark brings psychological changes that are arguably more important than the physical ones
Understanding Copper Peptides GHK-Cu is a naturally occurring copper-binding tripeptide found in the body